Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes

Detalles Bibliográficos
Autor principal: Malaria Research and Treatment
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610726/
https://www.ncbi.nlm.nih.gov/pubmed/31321025
http://dx.doi.org/10.1155/2019/4274315
_version_ 1783432553684795392
author Malaria Research and Treatment,
author_facet Malaria Research and Treatment,
author_sort Malaria Research and Treatment,
collection PubMed
description
format Online
Article
Text
id pubmed-6610726
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-66107262019-07-18 Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes Malaria Research and Treatment, Malar Res Treat Retraction Hindawi 2019-06-20 /pmc/articles/PMC6610726/ /pubmed/31321025 http://dx.doi.org/10.1155/2019/4274315 Text en Copyright © 2019 Malaria Research and Treatment. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Malaria Research and Treatment,
Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
title Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
title_full Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
title_fullStr Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
title_full_unstemmed Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
title_short Retracted: Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes
title_sort retracted: amodiaquine-artesunate versus artemether-lumefantrine against uncomplicated malaria in children less than 14 years in ngaoundere, north cameroon: efficacy, safety, and baseline drug resistant mutations in pfcrt, pfmdr1, and pfdhfr genes
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610726/
https://www.ncbi.nlm.nih.gov/pubmed/31321025
http://dx.doi.org/10.1155/2019/4274315
work_keys_str_mv AT malariaresearchandtreatment retractedamodiaquineartesunateversusartemetherlumefantrineagainstuncomplicatedmalariainchildrenlessthan14yearsinngaounderenorthcameroonefficacysafetyandbaselinedrugresistantmutationsinpfcrtpfmdr1andpfdhfrgenes

Ejemplares similares